# Mirum Pharmaceuticals, Inc. (MIRM)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MIRM/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 159.88M | $ -790.16M | $ -229.43M | $ 323.78M | $ 242.49M |
| 2025 | $ 533.78M | $ -23.92M | $ 56.19M | $ 319.45M | $ 314.69M |
| 2024 | $ 354.10M | $ -92.43M | $ -11.21M | $ 317.76M | $ 225.64M |
| 2023 | $ 201.52M | $ -176.69M | $ -98.45M | $ 308.14M | $ 248.67M |
| 2022 | $ 86.09M | $ -151.55M | $ -134.52M | $ 2.19M | $ 142.04M |
| 2021 | $ 22.75M | $ -99.83M | $ -180.42M | $ 2.61M | $ 120.21M |
| 2020 | $ 0 | $ -131.56M | $ -113.76M | $ 3.26M | $ 172.10M |
| 2019 | $ 0 | $ -67.83M | $ -51.17M | $ 3.65M | $ 130.35M |
| 2018 | $ 0 | $ -34.35M | $ -713.8K | $ 0 | $ 42.54M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 1.34 |
| Liabilities / Eq | 2.67 |
| Current Ratio | 2.09 |

## Other views

- [Metrics](https://sponda.capital/en/MIRM.md)
- [Charts](https://sponda.capital/en/MIRM/charts.md)
- [Compare](https://sponda.capital/en/MIRM/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.